⌘K

Login Start Free

Home/Filings/4/0000950170-25-074496

4//SEC Filing

Frohlich Tom 4

Accession 0000950170-25-074496

CIK 0001798749other

View on SEC.gov Company Profile

Filed

May 18, 8:00 PM ET

Accepted

May 19, 4:54 PM ET

Size

4.6 KB

Accession

0000950170-25-074496

Insider Transaction Report

Form 4

Period: 2025-05-16

Jade Biosciences, Inc.JBIO

DirectorChief Executive Officer

Transactions

Purchase
Common Stock
2025-05-16$7.40/sh+6,000$44,400→ 6,000 total

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Jade Biosciences, Inc.

CIK 0001798749

Entity typeother

Related Parties

1

filerCIK 0001823925

Filing Metadata

Form type: 4
Filed: May 18, 8:00 PM ET
Accepted: May 19, 4:54 PM ET
Size: 4.6 KB

View on SEC.gov